Ironwood Investment Counsel, LLC Gilead Sciences, Inc. Transaction History

Ironwood Investment Counsel, LLC

$532 Million
Q2 2024

A detailed history of Ironwood Investment Counsel, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ironwood Investment Counsel, LLC holds 5,485 shares of GILD stock, worth $494,856. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,485

Previous 5,289 3.71%

Holding current value

$494,856

Previous $387,000 2.84%

% of portfolio

0.07%

Previous 0.07%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $12,377 - $14,284	196 Added 3.71%	5,485 $376,000
Q1 2024 May 10, 2024	SELL	$71.58 - $87.29 $715 - $872	-10 Reduced 0.19%	5,289 $387,000
Q4 2023 Feb 07, 2024	SELL	$73.27 - $83.09 $219 - $249	-3 Reduced 0.06%	5,299 $429,000
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $25,213 - $27,508	341 Added 6.87%	5,302 $397,000
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $31,088 - $35,460	-409 Reduced 7.62%	4,961 $382,000
Q1 2023 May 11, 2023	SELL	$77.31 - $88.08 $31,078 - $35,408	-402 Reduced 6.96%	5,370 $445,000
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $13,211 - $18,967	212 Added 3.81%	5,772 $495,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $19,052 - $21,763	320 Added 6.11%	5,560 $343,000
Q2 2022 Aug 04, 2022	BUY	$57.72 - $65.01 $9,177 - $10,336	159 Added 3.13%	5,240 $323,000
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $8,688 - $10,887	150 Added 3.04%	5,081 $302,000
Q4 2021 Feb 04, 2022	SELL	$64.88 - $73.64 $4,476 - $5,081	-69 Reduced 1.38%	4,931 $358,000
Q3 2021 Nov 04, 2021	BUY	$67.69 - $73.03 $4,805 - $5,185	71 Added 1.44%	5,000 $349,000
Q2 2021 Aug 06, 2021	BUY	$63.47 - $69.35 $4,569 - $4,993	72 Added 1.48%	4,929 $339,000
Q1 2021 May 03, 2021	BUY	$60.0 - $68.46 $45,600 - $52,029	760 Added 18.55%	4,857 $313,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $6,061 - $6,906	-107 Reduced 2.55%	4,097 $238,000
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $22,418 - $28,186	361 Added 9.39%	4,204 $265,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $12,876 - $14,952	-178 Reduced 4.43%	3,843 $295,000
Q1 2020 Apr 29, 2020	SELL	$62.63 - $80.22 $6,638 - $8,503	-106 Reduced 2.57%	4,021 $300,000
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $12,015 - $13,217	195 Added 4.96%	4,127 $268,000
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $562 - $621	-9 Reduced 0.23%	3,932 $249,000
Q2 2019 Jul 29, 2019	BUY	$61.87 - $69.38 $19,117 - $21,438	309 Added 8.51%	3,941 $266,000
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $5,064 - $5,674	81 Added 2.28%	3,632 $236,000
Q4 2018 Jan 25, 2019	BUY	$60.54 - $79.0 $2,663 - $3,476	44 Added 1.25%	3,551 $222,000
Q3 2018 Oct 23, 2018	SELL	$71.28 - $78.92 $28,226 - $31,252	-396 Reduced 10.15%	3,507 $270,000
Q2 2018 Jul 26, 2018	BUY	$64.88 - $75.68 $253,226 - $295,379	3,903 New	3,903 $276,000

Others Institutions Holding GILD

# of Institutions

1,904

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ironwood Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ironwood Investment Counsel, LLC with notifications on news.

Account

Ironwood Investment Counsel, LLC Gilead Sciences, Inc. Transaction History